News Sentiment

688192 sentiment intelligence

Dizal (Jiangsu) Pharmaceutical Co., Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 50 Balanced news tone 4 relevant articles
Exchange SHH China
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 61.42 Week of 17 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

72/100 classification confidence.

Company focus 4

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+31.4% over one week, +61.8% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Neutral

Asia deal flurry draws AZ, Spero to $1B+ Dizal, Innovent assets

Market Reaction

Price moving ahead of tone

55/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 72/100 classification
One-week reaction 31.4% Price confirming higher
Trend fit Trend inactive 61.8% over four weeks
Fair value 25.9% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 0
Neutral 4
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 4
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
TradingView 2
BioWorld News 1
Reuters 1

Event Lens

What the news is about

Classified themes
Market update 3
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-4 of 4